News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

News|Articles|May 3, 2013

Orally Disintegrating Tablets

Author(s)Cynthia A. Challener

Podcast interview with Nick Johnson, Strategic Marketing Director for Modified Release Technologies at Catalent Pharma Solutions

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related Content

Matt Meyer, Governor, State of Delaware

A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision

ByZachary Zubulake,Christopher Cole

June 3rd 2026

Adeno-associated virus. AAV virus genome. Adenoviral pneumonia, arthritis, bronchitis, hepatitis, cystitis. Adenovirus as vectors for gene therapy. Genetic material transmission to cell. Biotech 3D | Image Source: ©Corona Borealis -stock.adobe.com

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance

June 3rd 2026

Generic GLP-1s Enter Canadian Market

ByErez Israeli,Susan Haigney

June 2nd 2026

Image Courtesy of MannKind Corporation

Implications of Pediatric Inhaled Insulin Approval

ByZachary Zubulake

June 1st 2026

PharmTech Weekly Roundup—May 29, 2026

BySusan Haigney

May 29th 2026

Trending on Pharmaceutical Technology

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance

Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs

Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape

A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision

CPHI Americas: How FDA Instability Is Reshaping Pharmaceutical Development